The ethanol extract of Moringa oleifera . Lam leaves and its major constituents, crypto-chlorogenic acid, quercetin 3-O-glucoside and kaempferol 3-Oglucoside, were investigated on the respiratory burst of human whole blood and isolated human polymorphonuclear leukocytes (PMNs) using a luminol-based chemiluminescence assay. The chemotactic migration of PMNs was also investigated using the Boyden chamber technique. The ethanol extract demonstrated inhibitory activities on the oxidative burst and the chemotactic migration of PMNs. Quercetin 3-O-glucoside, crypto-chlorogenic acid, and kaempferol 3-Oglucoside, isolated from the extract, expressed relatively strong inhibitory activity on the oxidative burst of PMNs with IC 50 values of 4.1, 6.7 and 7.0 µM, respectively, comparable with that of aspirin. They also demonstrated strong inhibition of chemotatic migration of PMNs with IC 50 values of 9.5, 15.9 and 18.2 µM, respectively. The results suggest that M. oleifera leaves could modulate the immune response of human phagocytes, linking to its ethnopharmacological use as an anti-inflammatory agent. The immunomodulating activity of the plant was mainly due to its major components.
Professional phagocytes, neutrophils and polymorphonuclear leukocytes (PMNs) are indispensable for the rapid eradication of infectious microbes and also play an important role in activating the adaptive immune response [1] . PMNs demolish and remove pathogenic agents through several mechanisms, such as chemotaxis, phagocytosis, and degranulation [2] . Numerous reactive oxygen species (ROS), including superoxide radical (O 2 -) and hypochlorite (HOCl -), are generated, after the stimulation of PMNs, to kill microbes [3a] . Overproduction of ROS can be deleterious to host cells and lead to various diseases such as arthritis, inflammatory bowel and asthma. Thus, inhibition of ROS is one of many pathways potentially taken in the treatment of various inflammatory disorders [4] .
Moringa oleifera Lam. (Moringaceae) is a small-medium sized tree that can grow well in humid tropics or hot dry areas. Different parts of this plant have been used for healing various ailments indigenously in Asia, Africa and South America [5a] . The leaves are used as an anti-bacterial, a poultice for sores, and can also treat stomachache, fever and sprains [5a, 5b] . Phytochemical studies demonstrated that the leaves of M. oleifera contained terpenoids, thiocarbamates and complex flavonoid compounds, which are responsible for antiatherosclerotic, anti-oxidative and hypolipidaemic activities [5c-5f]. Nevertheless, there is limited information available on the immunomodulatory effects of M. oleifera leaves. Therefore, we aimed to establish the effects of its ethanol extract and its major components on ROS production of human whole blood and isolated PMNs, and chemotaxis of PMNs induced by bacterial peptide N-formyl-methionylleucylphenylalanine (fMLP).
Our previous study [6] showed that crypto-chlorogenic acid, quercetin 3-O-glucoside and kaempferol 3-O-glucoside were the principal compounds of a 70% ethanol extract of M. oleifera leaves. A cell viability test indicated that more than 90% of the cells were viable after 2 h of incubation with 25 and 50 µg/mL of the ethanol extract and 6.25 and 12.5 µg/mL of the pure major compounds. Thus, 50 µg/mL of the extract and 12.5 µg/mL of each pure compound were selected as the concentrations for each assay. In the present study, an HPLC chromatogram of the ethanol leaf extract of M. oleifera detected and identified the three major components at retention times of 6.32, 20.26 and 25.25 min for crypto-chlorogenic acid, quercetin 3-O-glucoside and kaempferol 3-O-glucoside, respectively.
The chemiluminescence produced by the extract and the pure compounds on whole blood and PMNs showed that ROS generation was inhibited in a dose-dependent manner. The 70% ethanol extract possessed inhibitory activity, with IC 50 values of 26.2 ± 1.3 and 24.0 ± 0.7 µg/mL on the whole blood and PMNs, respectively. Crypto-chlorogenic acid, quercetin 3-O-glucoside and kaempferol 3-O-glucoside showed strong activity with IC 50 values of 8.5 ± 0.7, 5.7 ± 0.5 and 13.9 ± 1.7 µM on the whole blood and 6.7 ± 1.7, 4.1 ± 0.3 and 7.0 ± 0.8 µM on PMNs, respectively (Table 1) . Interestingly, the IC 50 values of these compounds were lower than that of the positive control, aspirin, (21.4 ± 3.9 µM). Luminol was used as a probe to detect the effect of the compounds on the specific ROS due to its low molecular weight and its ability to penetrate through the cell membrane to react with intracellular ROS that are primarily produced at a later phase of oxidative burst [3a, 3b] . Some researchers reported that phenolics and flavonoids, such as myricetin, kaempferol and galangin, had an inhibitory effect on the oxidative burst of PMNs for luminol-enchance chemiluminescence [4]. In the inflammatory process, PMNs release ROS that are implicated in tissue damage [4] . Thus, control over oxidative metabolism by a ROS scavenger could be of therapeutic benefit in the treatment of inflammation.
The effect of the M. oleifera leaf extracts and its major components on PMN chemotaxis was evaluated using the Boyden chamber method and their IC 50 values are shown in Table 1 . The 70% ethanol extract inhibited the migration of PMNs with an IC 50 value of 21.8 ± 4.2 µg/mL, while crypto-chlorogenic acid, quercetin 3-O-glucoside and kaempferol 3-O-glucoside demonstrated IC 50 values of 15.9 ± 3.1, 9.5 ± 3.3 and 18.2 ± 2.6 µM, respectively. Ibuprofen was selected as a positive control because of its strong activity in blocking directional movement [7a] . Several flavonoids have antiinflammatory activity and some can strongly inhibit fMLP-induced neutrophil chemotaxis [7b]. In this study, quercetin 3-O-glucoside exhibited strong inhibitory activity with an IC 50 value of 9.5 µM, which was comparable to that of ibuprofen (9.4 µM) ( Table 1) .
Anti-inflammatory activity of flavonoids, phenolics and their glycosides were reported in many mechanisms such as suppression of mouse lymphocyte proliferation, inhibition of alpha tumor necrosis factor, and inhibition of lipopolysaccharide -induced acute pulmonary inflammation in mice [8a-8c] . However, the effect of these compounds on intracellular ROS and chemotactic migration of human phagocytes are limited. Therefore, we demonstrated the inhibitory activities of M. oleifera leaf extracts and its three major active compounds on ROS and chemotactic migration of human phagocytes for the first time. These results justify the traditional uses of M. oleifera leaves as an anti-inflammatory agent and also support the results of previous studies [5b ,9] . Additionally, the major phenolic compounds, crypto-chlorogenic acid, quercetin 3-Oglucoside and kaempferol 3-O-glucoside, mainly accounted for the anti-inflammatory activity of this plant.
Experimental

Chemicals and equipment:
Luminol (3-aminophthalhydrazide), serum opsonized zymosan A (Sacromyces cerevisae suspensions and serum), phosphate buffer saline tablet (PBS), dimethylsulfoxide (DMSO), Hanks balance salt solutions (HBSS ++ ), Hanks balance salt solution (HBSS -), Ficoll, N-formylmethionylleucylphenylalanine (fMLP), acetylsalicylic acid (purity > 99%), ibuprofen (purity > 99%), ethanol and methanol of analytical grades were purchased from Sigma (St Louis, MO, USA). The other solvents were of analytical grade and purchased from Labscan Asia (Thailand). Chemiluminescense measurements were carried out on a Luminoskan Ascent luminometer (Thermo Scientific, UK). fMLP was stored as a stock solution of 10 -8 M in DMSO at -80°C and diluted in Hanks solution prior to assay. Haematoxylin and xylene for staining were obtained from BDH (UK). A Boyden 48-well chamber with a 2 µm polycarbonate membrane filter separating the upper and lower compartments was purchased from Neuro Probe (Cabin John, MD, USA). A CO 2 incubator (Shell Lab, USA) and light microscope (LeitzWatzler, Germany) were used in this assay.
Plant materials:
The leaves of M. oleifera were collected from Chiang Mai Province, Thailand in March 2011. The samples were identified by Dr W. Gritsanapan, and the voucher specimen (BVMO11008), was deposited at the Department of Pharmacognosy, Faculty of Pharmacy, Mahidol University, Bangkok. The leaves were dried in a hot oven at 60°C for 24 h. The dried samples were ground and passed through a sieve (20 mesh).
Preparation of the leaf extract:
The leaf power (150 g) was extracted by maceration with 70% ethanol, which was found to be the appropriate extraction method and solvent for M. oleifera leaves [10] . The ethanolic extract was concentrated using a rotary evaporator to yield the dried extract (42 g). This was kept in a sealed glass bottle protected from light at 4°C until used.
Qualitative analysis of major active compounds by HPLC:
Cryptochlorogenic acid, quercetin 3-O-glucoside and kaempferol 3-Oglucoside were separated and purified in our previous work [6] . The HPLC chromatogram of the 70% ethanolic leaf extract of M. oleifera was performed on a Shimadzu SPD-10A HPLC (Japan). The separation was carried out on a Hypersil ® BDS C 18 -column (4.6 x 150mm i.d., 5 mm) with a C 18 guard column. A gradient elution program was used with solvent A (1% glacial acetic acid) and solvent B (methanol).
Isolation of human polymorphonuclear leukocytes (PMNs):
Venous blood was obtained in heparin-containing tubes by aseptic vein puncture from healthy human volunteers aged over 18 years old who fulfilled the following inclusion criteria: non-smoker, fasted overnight, and not taking any medicine or supplements. The blood was diluted with PBS (pH 7.4). Dextran was added and the mixture was left for 45 min at room temperature (26°C) for sedimentation. The supernatant was centrifuged by Ficoll-gradient separation and then washed twice with distilled water to remove red blood cells. A pellet of PMNs was collected from the tube base. The cells were suspended in HBSS ++ (pH 7.4). Cell suspensions were counted using a haemocytometer and light microscope, and diluted with HBSS ++ to obtain a final cell suspension of 1 x 10 6 /mL [11] . The use of human blood was approved by the Human Ethical Committee of UKM (approval no. FF-220-2008).
Cell viability:
Cell viability was determined by the standard trypan blue exclusion method. The PMNs (1 x 10 6 / mL) were incubated with 25, 50 and 100 µg/mL of plant extracts and 6.25, 12.5 and 25µg/mL of each pure compound, each in triplicate at room temperature for 2 h. The blue dye uptake was an indication of cell death. The percent viability was calculated from the total cell counts [11] .
Chemiluminescence assay: Luminol-based chemiluminescence assay was carried out as described by Jantan et al. [11] The luminol was used as a probe to detect the level of ROS affected by the plant extract and its major compounds. For the assay, either 25 µL diluted whole blood (1: 50 dilution in sterile PBS, pH 7.4) or 25 µL of Effect of Moringa oleifera on chemiluminescence and chemotactic activities Natural Product Communications Vol. 8 (11) 2013 1561 PMN (1 x 10 6 /mL), suspended in HBSS ++ was incubated with 25 µL serial dilutions of the plant extract and its major compounds in DMSO and H 2 O (5: 95 ratio) (6.25-100.00 µg/mL and 6.25-100.00 µg/mL, respectively). The cells were stimulated with 25 µL of opsonized zymosan, followed by 25 µL of luminol (7 x 10 -5 M), and then HBSS ++ was added to adjust the final volume to 200 µL. The final concentrations of the samples in the mixture were 12.5, 6.25, 3.13, 1.56 and 0.78 µg/mL. Tests were performed in white 96-well microplates, which were incubated at 37°C for 50 min in the thermostatically controlled chamber of the luminometer. The control wells contained 0.6% DMSO, HBSS ++ , luminol and cells, but no compounds. Acetylsalicylic acid, a non-steroidal antiinflammatory drug (NSAID), was used as a positive control. The final concentration of DMSO in the mixture was 0.6%, to eliminate the effect of the solvent on the chemiluminescence. The luminometer results were monitored as the chemiluminescence reading per luminometer unit (RLU) with peak and total integral values set with repeated scans at 30 s intervals and 1 s points measuring time. The inhibition percentage (%) for each compound was calculated using the following formula:
Chemotaxis assay:
The assay was carried out using a modified 48well Boyden chamber with formyl-methionyl-leucyl-phenylalanine (fMLP) as a chemotaxin, as previously described by Jantan et al. [11] In short, aliquots of 25 µL of fMLP (10 -8 M) were added to the lower chamber. Serial dilutions (5 µL) of each compound in DMSO and H 2 O (5: 95 ratio) were added 6 times each (n = 6) to the upper chamber containing 45 µL of PMNs (1 x 10 6 cells per mL) suspended in HBSS and incubated for 1 h at 37°C in a CO 2 incubator. The final concentrations of the samples in the mixture were 12.5, 6.25, 3.13, 1.56 and 0.78 µg/mL. The final concentration of DMSO in the reaction mixture was fixed at 0.5% to avoid interference with the chemotactic study. Migrated cells that had adhered to the distal part of the filters were fixed and stained with haematoxylin and xylene. The cell migration distance was measured by a light microscope. The chemoattractant buffer (DMSO and HBSS, 1: 1 ratio) was added as a control and ibuprofen was used as a positive control. The chemotactic effect of each compound was measured at different concentrations. The percentage inhibition (%) was calculated using the following formula:
(Travelled distance control -Travelled distance sample ) x 100/ Travelled distance control Statistical analysis: All data were analyzed using Statistical Package for Social Sciences (SPSS) version 16.0. Each sample was measured in triplicate and the data are presented as mean ± standard deviation (SD). The values were obtained from at least 3 determinations. Data were analyzed using a one-way analysis of variance (ANOVA) for multiple comparisons. P <0.05 was considered to be statistically significant.
